GEP19991639B - DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation - Google Patents
DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical FormulationInfo
- Publication number
- GEP19991639B GEP19991639B GEAP1993984A GEAP1993000984A GEP19991639B GE P19991639 B GEP19991639 B GE P19991639B GE AP1993984 A GEAP1993984 A GE AP1993984A GE AP1993000984 A GEAP1993000984 A GE AP1993000984A GE P19991639 B GEP19991639 B GE P19991639B
- Authority
- GE
- Georgia
- Prior art keywords
- epo
- polypeptides
- dna sequences
- dna
- polypeptide
- Prior art date
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000282693 Cercopithecidae Species 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000006166 lysate Substances 0.000 abstract 1
- 239000013600 plasmid vector Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 230000003362 replicative effect Effects 0.000 abstract 1
- 239000013603 viral vector Substances 0.000 abstract 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65584184A | 1984-09-28 | 1984-09-28 | |
| US06/675,298 US4703008A (en) | 1983-12-13 | 1984-11-30 | DNA sequences encoding erythropoietin |
| UA3917560A UA54363C2 (uk) | 1984-09-28 | 1985-06-19 | Виділена молекула днк, яка кодує людський еритропоетин (варіанти), біологічно функціональний кільцевий плазмідний або вірусний днк-вектор, штам еукаріотичних клітин-хазяїв (варіанти), спосіб одержання поліпептиду, фармацевтична композиція |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP19991639B true GEP19991639B (en) | 1999-03-23 |
Family
ID=27097052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP1993984A GEP19991639B (en) | 1984-09-28 | 1993-07-09 | DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation |
Country Status (9)
| Country | Link |
|---|---|
| CN (1) | CN1016795B (pm) |
| CZ (1) | CZ281542B6 (pm) |
| FI (1) | FI93470C (pm) |
| GE (1) | GEP19991639B (pm) |
| GR (1) | GR852245B (pm) |
| HU (1) | HU204889B (pm) |
| NO (1) | NO852384L (pm) |
| PT (1) | PT81213B (pm) |
| SK (1) | SK443885A3 (pm) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106608906A (zh) * | 2015-10-22 | 2017-05-03 | 天津药物研究院有限公司 | 一种具有刺激红细胞生成功能的环形多肽的制备及其应用 |
-
1985
- 1985-06-13 NO NO852384A patent/NO852384L/no unknown
- 1985-06-14 FI FI852377A patent/FI93470C/fi not_active IP Right Cessation
- 1985-06-18 CZ CS854438A patent/CZ281542B6/cs not_active IP Right Cessation
- 1985-06-18 SK SK4438-85A patent/SK443885A3/sk unknown
- 1985-06-18 HU HU852404A patent/HU204889B/hu unknown
- 1985-06-19 CN CN85106191A patent/CN1016795B/zh not_active Expired
- 1985-09-16 GR GR852245A patent/GR852245B/el unknown
- 1985-09-27 PT PT81213A patent/PT81213B/pt unknown
-
1993
- 1993-07-09 GE GEAP1993984A patent/GEP19991639B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT40694A (en) | 1987-01-28 |
| HU204889B (en) | 1992-02-28 |
| FI93470B (fi) | 1994-12-30 |
| SK279959B6 (sk) | 1999-06-11 |
| FI852377L (fi) | 1986-03-29 |
| FI93470C (fi) | 1995-04-10 |
| CZ443885A3 (en) | 1996-09-11 |
| CZ281542B6 (cs) | 1996-11-13 |
| PT81213A (en) | 1985-10-01 |
| PT81213B (pt) | 1987-09-30 |
| CN85106191A (zh) | 1987-07-29 |
| GR852245B (pm) | 1986-01-17 |
| CN1016795B (zh) | 1992-05-27 |
| NO852384L (no) | 1986-04-01 |
| FI852377A0 (fi) | 1985-06-14 |
| SK443885A3 (en) | 1999-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032250L (no) | Anvendelse av et hpG-CSF-polypeptid til fremstilling av et medikament for åstanse proliferasjon av leukemiceller | |
| ES8802329A1 (es) | Un procedimiento para preparar un polipetido que tiene en parte o en su totalidad la conformacion estructural primaria de la critropoyetina de origen natural. | |
| DK163187C (da) | Fremgangsmaader til fremstilling af humant immuninterferon (gamma-interferon) samt dna-fragmenter, rekombinante klonings- og udtrykkelsesvektorer og rekombinante mikroorganismer og cellekulturer til anvendelse herved | |
| AU2790292A (en) | Viral recombinant vectors for expression in muscle cells | |
| BG60250B1 (bg) | Метод за получаване на тумор некрозис фактор | |
| NZ218332A (en) | Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition | |
| IL88151A (en) | Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it | |
| EP0275204A3 (en) | Production of fibroblast growth factor | |
| EP0111814A3 (en) | The cloning and expression of nucleotide sequences encoding bovine growth hormone | |
| EP2145961A3 (en) | Porcine adenovirus type 3 genome | |
| AU2002314183A1 (en) | Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene | |
| GEP19991639B (en) | DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation | |
| HIRSCHBERG et al. | Stimulation of human lymphocytes by cultured allogeneic skin and endothelial cells in vitro | |
| Souza | Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor | |
| DK200301683A (da) | DNA-sekvens kodende for polypeptidet [la1]hpG-CSF, plasmider indeholdende sekvensen, hermed transformerede/transficerede værtsceller...... |